Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer

The goal of this clinical trial is to investigate if weekly symptom monitoring of patients with advanced lung cancer is associated with better survival and improved quality of life compared to standard follow-up.Each week, participants in the intervention group will be asked to respond to an electronic weekly questionnaire covering 11 items related to current health status.

Inclusion Criteria:Histologically or cytology proven non-small cell lung cancer (NSCLC)NSCLC stage III or IV≥ 18 yearsECOG performance status 0- 2Eligible patients should have initiated first-line treatment for advanced or metastatic disease with chemotherapy and/or immunotherapy, radiochemotherapy or targeted treatmentPatients are eligible for inclusion if they have responded to first-line treatment with stable disease, or better, at the first radiological evaluation performed up to six months after start of treatmentStable disease, or better, on radiological assessment within 28 days of enrolment (CT scan or FDG-PET/CT. Cerebral MRI if known brain metastasis)Initial web-based application score of ≤ 6Basic computer literacyBank-ID (electronic identification system) and access to "1177 Vårdguiden"The subject has given written consent to participate in the studyExclusion Criteria:Symptomatic brain metastasesPregnancy, breastfeeding, or planned pregnancyPersons under guardianship or deprived of libertyMental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participationTreatment or disease which, according to the investigator, can affect treatment or study resultsOngoing participation in another interventional clinical study